Cognate Insights

[null]

Media Inquiries

Cognate’s team is available to discuss our recent news further.

Contact

Charles River Laboratories Completes the Acquisition of Cognate BioServices

WILMINGTON, Mass.--(BUSINESS WIRE)--Mar. 29, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously... Read More

Charles River Laboratories to Acquire Cognate BioServices

Charles River Laboratories to Acquire Cognate BioServices – Significantly Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy Sector – –... Read More

Cognate and Nucleus Biologics announce partnership in Cell and Gene Therapies

MEMPHIS, Tennessee, January, 27 2021 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready global CDMO in the Cell and Gene Therapy industry, and Nucleus... Read More

Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe

Cognate BioServices, Inc., the premier commercial-ready, global CDMO in the Cell and Gene Therapy industry, announced today its plans to expand cell and gene therapy... Read More

Cognate BioServices, the Leading Biologics CDMO, Selects L7 Informatics to Implement L7|ESP for Integrated Manufacturing and Lab Operations

L7 Informatics announced that it has partnered with Cognate BioServices, Inc., the premier commercial-ready CDMO in the Cell & Gene Therapy industry, to deploy L7|ESP... Read More

Cognate BioServices Names Tom Pamukcoglu as VP, Global Head of Quality

MEMPHIS, Tennessee, November 2, 2020 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready CDMO in the Cell & Gene Therapy industry, announced today the... Read More

J. Kelly Ganjei of Cognate announced as an Entrepreneur Of The Year® 2020 Southeast Award Finalist

Ernst & Young LLP (EY US) today announced that J. Kelly Ganjei, CEO of Cognate BioServices, Inc. was named an Entrepreneur Of The Year® 2020 Southeast Award finalist. Now in... Read More

Cognate Announces the Appointment of Two Independent Board Members

MEMPHIS, Tennessee, August 20, 2020/PRNewswire/ -- Cognate BioServices, Inc. announced today the appointments of Timothy Moore and Steven Kasok as independent non-executive... Read More

Cognate Reveals New Brand Identity with Redesigned Logo and Website

  Read More

Cognate BioServices closes Series B and completes acquisition of Cobra Biologics

MEMPHIS, Tenn., January 21, 2019 /PRNewswire/ — Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated... Read More
No More Posts